Spotlight on Long Covid: Part 3

At least 65 million individuals worldwide are estimated to have Long Covid, and more than 200 symptoms have been identified and attached to this often-debilitating illness*. Three years on from the start of the pandemic we continue to navigate and build our understanding of Long Covid’s impact, its best treatment pathways and question what the future holds.

Following on from their first two episodes in this series, The Royal Society of Medicine return to the topic with ‘Spotlight on Long Covid, part 3’. This extended webinar programme will present the most up-to-date knowledge of the condition, highlight findings from ongoing research and share key insights from clinicians, researchers and patients.

Joining the webinar will be researchers from the LOCOMOTION study**, a £3.4 million project identifying the best ways to treat and support Long Covid, alongside clinicians who lead on the treatment, service development and our understanding of the long-term effects of COVID-19.

By attending this webinar, you will:

• Receive an update on the latest statistics and research surrounding Long Covid
• Receive advice on how to manage and support patients with Long Covid
• Understand the treatment pathways currently available for those with Long Covid and how these pathways are resourced within the NHS
• Dive deeper into the key health topics within Long Covid, looking at symptoms, treatment, research and patient experience

Register